DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
John Ransom - 4 Raymond James - 3 Coupang - 2 Tesla - 2 Armour - 1 FactSet - 1 Goose - 1 Warren Buffett's Berkshire Hathaway - 1
Top related locs:
Krakow Poland The Seattle Korea U.S Red California
Top related orgs:
Wall - 2 UBS - 2 Walmart - 1 LSEG - 1 Revenue - 1 — - 1 Berkshire - 1 Cisco Systems - 1

Search resuls for: "John Ransom"


11 mentions found


☆ Stocks making biggest moves premarket: Under Armour, Walmart, AMC, GameStop, Canada Goose and more
  + stars: | 2024-05-16 | by ( Brian Evans | ) www.cnbc.com   time to read: +3 min
Under Armour — The sportswear maker's Class A shares slumped 11% and its Class C stock fell 9% after it issued lower-than-expected full-year earnings guidance. Under Armour now expects earnings in the range of 18 cents to 21 cents while analysts polled by FactSet had forecast 59 cents. Cisco Systems also hiked its 2024 revenue guidance, saying it now expects revenue of $53.7 billion at the midpoint of a range. Meme stocks — Shares of AMC and GameStop extended losses following the revival of the meme stock movement on Monday and Tuesday. Baidu reported CNY 31.51 billion ($4.7 billion) of revenue, topping the CNY 31.34 billion expected by analysts, according to StreetAccount.
Persons: Armour, FactSet, Goose, Warren Buffett's Berkshire Hathaway, Chubb, Deere, GoodRX, Raymond James, John Ransom, Coupang, Tesla, — CNBC's Michelle Fox, Hakyung Kim, Sarah Min, Samantha Subin, Jesse Pound Organizations: Walmart, Wall, LSEG, Revenue, —, Berkshire, Cisco Systems, AMC, GameStop, Deere, Company, Baidu, UBS, ISI, European Union, Facebook Locations: Krakow, Poland, The Seattle
☆ Thursday's analyst calls: Fast food stock to surge 40%, what to expect from Nvidia earnings
  + stars: | 2024-05-16 | by ( Pia Singh Fred Imbert | Pia Singh | Fred Imbert | ) www.cnbc.com   time to read: +8 min
A fast food stock and Nvidia were among the stocks being talked about by analysts on Wall Street. RBC assumed coverage of Jack in the Box with an outperform rating and a price target that implies more than 40% upside. Ransom's $10 price target implies about 37.6% potential upside for the stock, which has gained 8.5% this year. Mailk said he likes the buy-rated stock on "secular AI growth opportunities" and maintained his $1,030 price target. New Street Research maintained its buy rating and $1,100 price target ahead of the quarterly print.
Persons: Jack, Piper Sandler, GoodRx, Raymond James Raymond James, John Ransom, — Pia Singh, Tesla, Dell, Amit Daryanani, Daryanani, Wolfe, Chris Caso, Caso, INTC, Coupang, Jennifer Han, Han, that's, Nvidia's, Piper Sandler's Harsh Kumar, Kumar, Blackwell, Atif Malik, Mailk, Pierre Ferragu, Logan Reich, JACK YTD, Fred Imbert Organizations: CNBC, Nvidia, Wall, RBC, Citi, New, Research, Kroger, pharma, Dell, DELL, Wolfe Research, Intel, UBS, Blackwell, RBC Capital Markets Locations: Korea
☆ Raymond James' John Ransom weighs in on Walgreens' slumping stock
  + stars: | 2023-09-01 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailRaymond James' John Ransom weighs in on Walgreens' slumping stockJohn Ransom, Raymond James, joins 'Closing Bell' to discuss Walgreens shares slumping even further after its CEO stepped down.
Persons: Raymond James, John Ransom Organizations: Walgreens
☆ CVS pushes into making cheaper versions of complex drugs with new discount Humira
  + stars: | 2023-08-23 | by ( Bertha Coombs | ) www.cnbc.com   time to read: +4 min
CVS Health is partnering with drugmaker Sandoz to produce a near identical version of the blockbuster arthritis treatment Humira that will sell for 80% below the price of the brand-named drug. The move is part of the company's new venture focused on securing, and in some cases co-producing, biosimilar drugs, which are the equivalent of generic versions of complex gene or protein-based therapies known as biologics. CVS is already one of the leading players when it comes to sourcing generic drugs through Red Oak, its joint venture with Cardinal Health . Abbvie reported more than $4 billion in Humira sales in its most recent quarter, which was slightly better than expected. Correction: CVS Health subsidiary Cordavis will partner with Sandoz on biosimilar drugs.
Persons: drugmaker Sandoz, We've, it'll, Prem Shah, drugmaker, Amgen's Amjevita, Murdo Gordon, Abbvie, Cuban's, John Ransom, Raymond James, Ransom, Sandoz Organizations: CVS Health, CVS, Cardinal Health, Novartis Pharmaceuticals, Sandoz, Novartis, FDA, Blue, Drug Company, Amazon Pharmacy Locations: U.S, Red, California
☆ Raymond James' John Ransom weighs in on UnitedHealth's earnings beat
  + stars: | 2023-04-14 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailRaymond James' John Ransom weighs in on UnitedHealth's earnings beatCNBC's Bertha Coombs with John Ransom, Raymond James, joins 'The Exchange' to discuss UnitedHealth.
☆ UnitedHealth can estimate 13-16% EPS growth and they won't miss that: Raymond James' Ransom
  + stars: | 2023-04-11 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailUnitedHealth can estimate 13-16% EPS growth and they won't miss that: Raymond James' RansomJohn Ransom, Raymond James managing director of healthcare equity research, joins 'Power Lunch' to discuss what's at stake in UnitedHealth's earnings results, how long the company can continue to grow and more.
☆ Raymond James upgrades UnitedHealth and Cigna to strong buy
  + stars: | 2023-04-05 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailRaymond James upgrades UnitedHealth and Cigna to strong buyJohn Ransom, Raymond James, on his bullish call on two insurance stocks.
☆ Raymond James sees this health insurance giant's stock gaining more than 25%
  + stars: | 2023-04-05 | by ( Hakyung Kim | Https | Www.Linkedin.Com In Hakyungkim | ) www.cnbc.com   time to read: +1 min
UnitedHealth shares are well-positioned to have a strong 2023, according to Raymond James. Analyst John Ransom upgraded shares of UnitedHealth to strong buy from outperform. UnitedHealth shares are down 7% in 2023, lagging the S & P 500's 6.8% advance. UNH YTD mountain UNH in 2023 Ransom said that many of the policy overhangs on UnitedHealth, which accounted for his previous downgrade in December, are now past the company. Raymond James sees these measures as "a win for the industry as it buffers the initial impact and buys time for behavior changes.
☆ Wall Street analysts say these A.I. beneficiaries have major upside, including this cancer detection company
  + stars: | 2023-03-11 | by ( Michael Bloom | ) www.cnbc.com   time to read: +7 min
Wall Street analysts named several stocks this week they see as major beneficiaries of the recent artificial intelligence boom. They include Adobe, Marvell, RadNet, Cisco, TSM and Broadcom. RadNet The outpatient radiology diagnostic center company was recently upgraded to outperform from market perform by Raymond James analyst John Ransom. "With strong structural tailwinds, MSD-HSD EBITDA growth should be achievable in the near to intermediate-term, with an enticing opportunity in the AI segment," Ransom said. ... With strong structural tailwinds, MSD-HSD EBITDA growth should be achievable in the near to intermediate-term, with an enticing opportunity in the AI segment.
☆ A booming market for gear to help seniors grow older at home is creating an opportunity for investors
  + stars: | 2023-01-21 | by ( Michelle Fox | ) www.cnbc.com   time to read: +13 min
Alphabet, Amazon and Best Buy are among the fund's plays on the aging in place theme. Best Buy breaks into the space It's Best Buy that has really been doubling down on its efforts to break into the space. Best Buy sees the role of technology within health care becoming much more important. Medicare Advantage's health care at home coverage includes primary care, transitional care when someone is released from a hospital and often hospice care, she said. That should lead to higher earnings power, said Baker, who has a buy rating and $237 price target on Lowe's stock.
☆ Walgreens Chases Customers It Lost During Covid Focus
  + stars: | 2022-10-14 | by ( Katie Deighton | ) www.wsj.com   time to read: +4 min
Walgreens Boots Alliance Inc. is planning to reinvigorate its pharmacy business partly through a marketing push designed to regain customers that stopped spending with the chain during the Covid-19 pandemic. The program lets executives analyze where customers are shopping and what they are buying, and use that information to reach out to them with more personalized marketing, Ms. “This is primarily a digital plan.”Walgreens plans to assess data to group customers into various communities, depending on what their needs are and where they shop, according to Ms. Brown, the customer chief. But a community of “support seekers,” who may need more pharmacy support, would be targeted with marketing around a store’s pharmacy services, Ms. Brown said. Walgreens in May named former Calvin Klein executive Linh Peters as its chief marketing officer, in part because of her experience leading marketing and loyalty programs at Starbucks, Best Buy, Target and Ulta.
0 next >>
Total: 11